These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19476490)
1. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. Wenke AK; Grässel S; Moser M; Bosserhoff AK FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490 [TBL] [Abstract][Full Text] [Related]
2. The transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1). Niebler S; Bosserhoff AK FEBS J; 2013 Mar; 280(6):1397-408. PubMed ID: 23331625 [TBL] [Abstract][Full Text] [Related]
3. Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2epsilon and Ets-1. Wenke AK; Rothhammer T; Moser M; Bosserhoff AK Biochem Biophys Res Commun; 2006 Jun; 345(1):495-501. PubMed ID: 16684505 [TBL] [Abstract][Full Text] [Related]
4. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Ikegami D; Akiyama H; Suzuki A; Nakamura T; Nakano T; Yoshikawa H; Tsumaki N Development; 2011 Apr; 138(8):1507-19. PubMed ID: 21367821 [TBL] [Abstract][Full Text] [Related]
5. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling. Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284 [TBL] [Abstract][Full Text] [Related]
7. Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha. Huang Z; Xu H; Sandell L J Bone Miner Res; 2004 Feb; 19(2):245-55. PubMed ID: 14969394 [TBL] [Abstract][Full Text] [Related]
8. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907 [TBL] [Abstract][Full Text] [Related]
9. Sox9 is required for cartilage formation. Bi W; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B Nat Genet; 1999 May; 22(1):85-9. PubMed ID: 10319868 [TBL] [Abstract][Full Text] [Related]
10. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Robins JC; Akeno N; Mukherjee A; Dalal RR; Aronow BJ; Koopman P; Clemens TL Bone; 2005 Sep; 37(3):313-22. PubMed ID: 16023419 [TBL] [Abstract][Full Text] [Related]
12. Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage. Asou Y; Nifuji A; Tsuji K; Shinomiya K; Olson EN; Koopman P; Noda M J Orthop Res; 2002 Jul; 20(4):827-33. PubMed ID: 12168674 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-Inducible Factor 1 Is an Inductor of Transcription Factor Activating Protein 2 Epsilon Expression during Chondrogenic Differentiation. Niebler S; Angele P; Kujat R; Bosserhoff AK Biomed Res Int; 2015; 2015():380590. PubMed ID: 26273614 [TBL] [Abstract][Full Text] [Related]
14. Serine racemase suppresses chondrogenic differentiation in cartilage in a Sox9-dependent manner. Takarada T; Hinoi E; Takahata Y; Yoneda Y J Cell Physiol; 2008 May; 215(2):320-8. PubMed ID: 17929246 [TBL] [Abstract][Full Text] [Related]
15. Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme. Kulyk WM; Franklin JL; Hoffman LM Exp Cell Res; 2000 Mar; 255(2):327-32. PubMed ID: 10694448 [TBL] [Abstract][Full Text] [Related]
17. Activating enhancer binding protein 2 epsilon (AP-2ε)-deficient mice exhibit increased matrix metalloproteinase 13 expression and progressive osteoarthritis development. Niebler S; Schubert T; Hunziker EB; Bosserhoff AK Arthritis Res Ther; 2015 May; 17(1):119. PubMed ID: 25964075 [TBL] [Abstract][Full Text] [Related]
18. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro. Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932 [TBL] [Abstract][Full Text] [Related]
19. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Amarilio R; Viukov SV; Sharir A; Eshkar-Oren I; Johnson RS; Zelzer E Development; 2007 Nov; 134(21):3917-28. PubMed ID: 17913788 [TBL] [Abstract][Full Text] [Related]
20. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Ikeda T; Kamekura S; Mabuchi A; Kou I; Seki S; Takato T; Nakamura K; Kawaguchi H; Ikegawa S; Chung UI Arthritis Rheum; 2004 Nov; 50(11):3561-73. PubMed ID: 15529345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]